We are live on
!
Find out more
BCM
Beryl Capital Management Portfolio holdings
AUM
$111M
1-Year Est. Return
205.39%
This Fund
S&P 500
This Quarter
Est. Return
+12.72%
1 Year Est. Return
+205.39%
3 Year Est. Return
+3,931.93%
5 Year Est. Return
+11,104.4%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$937K
(+0.85%)
Cap. Flow
-$3.56M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
7
Increased
–
Reduced
–
Closed
9
Avg Time Held Equity + Options
0
quarters
Top 10 Avg Time Held Equity + Options
0
quarters
Top 20 Avg Time Held Equity + Options
0
quarters
Avg Time Held Equity only
0
quarters
Top 10 Avg Time Held Equity only
0
quarters
Top 20 Avg Time Held Equity only
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Janus Henderson
JHG
|
+$73.1M |
| 2 |
Esperion Therapeutics
ESPR
|
+$12.4M |
| 3 |
SILA
Sila Realty Trust
SILA
|
+$5.85M |
| 4 |
Apogee Therapeutics
APGE
|
+$5.29M |
| 5 |
Avanos Medical
AVNS
|
+$3.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Masimo
MASI
|
+$38.6M |
| 2 |
Terns Pharmaceuticals
TERN
|
+$25.2M |
| 3 |
Great Lakes Dredge & Dock
GLDD
|
+$15.5M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
+$11M |
| 5 |
STKL
SunOpta
STKL
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 66.44% |
| 2 | Healthcare | 23.18% |
| 3 | Real Estate | 5.49% |
| 4 | Consumer Discretionary | 3.24% |
| 5 | Technology | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
DELISTED
Janus Henderson
JHG
| $73.5M | 66.44% |
+1,414,000
| New | +$73.1M |
2026 Q2
0 quarters
|
|
|
2
DELISTED
Esperion Therapeutics
ESPR
| $14M | 12.65% |
+4,431,598
| New | +$12.4M |
2026 Q2
0 quarters
|
|
|
3
DELISTED
Apogee Therapeutics
APGE
| $7.79M | 7.04% |
+58,676
| New | +$5.29M |
2026 Q2
0 quarters
|
|
|
SILA
4
DELISTED
Sila Realty Trust
SILA
| $6.07M | 5.49% |
+200,000
| New | +$5.85M |
2026 Q2
0 quarters
|
|
|
5
DELISTED
Avanos Medical
AVNS
| $3.86M | 3.49% |
+155,056
| New | +$3.63M |
2026 Q2
0 quarters
|
|
6
DELISTED
Taylor Morrison
TMHC
| $3.59M | 3.24% |
+50,000
| New | +$3.18M |
2026 Q2
0 quarters
|
|
7
TD Synnex
SNX
$21.8B
| $1.83M | 1.66% |
+6,853
| New | +$1.65M |
2026 Q2
0 quarters
|
|
8
Adeia
ADEA
$2.56B
| – | – |
-121,129
| Closed | -$2.91M | – |
|
|
9
DELISTED
Day One Biopharmaceuticals
DAWN
| – | – |
-514,114
| Closed | -$11M | – |
|
10
DELISTED
Farmer Brothers
FARM
| – | – |
-336,725
| Closed | -$428K | – |
|
|
11
DELISTED
Great Lakes Dredge & Dock
GLDD
| – | – |
-912,537
| Closed | -$15.5M | – |
|
12
CALL
Hallador Energy
HNRG
$686M
| – | – |
-66,500
| Closed | -$1.08M | – |
|
|
13
DELISTED
Masimo
MASI
| – | – |
-217,103
| Closed | -$38.6M | – |
|
|
STKL
14
DELISTED
SunOpta
STKL
| – | – |
-1,508,377
| Closed | -$9.77M | – |
|
|
15
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-478,755
| Closed | -$25.2M | – |
|
16
DELISTED
Warner Bros
WBD
| – | – |
-187,354
| Closed | -$5.14M | – |
|
Similar funds
WPWM
SM
IWA
BFA
DI
ZS
KC
FI
Beryl Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Beryl Capital Management held 16 positions worth $111M, up 0.85% from $110M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Beryl Capital Management withdrew a net $3.56M in Q2 2026, closing 9 positions. Its most notable exit was Masimo, an estimated $38.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 66% of assets, followed by Healthcare and Real Estate.
Against the trend, Beryl Capital Management opened a new position in Janus Henderson worth $73.5M.
- Beryl Capital Management's largest Q2 2026 buy was Janus Henderson: 1,414,000 shares worth $73.5M.
- Beryl Capital Management fully exited Masimo in Q2 2026, selling an estimated $38.6M.
- Beryl Capital Management's ten largest holdings make up 100% of its $111M portfolio in Q2 2026.
- Beryl Capital Management opened 7 new positions and closed 9 in Q2 2026.
- Beryl Capital Management's portfolio value rose 0.85% quarter-over-quarter to $111M.
Based on Beryl Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.